- Filed
- Nov 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 31, 2025 | 172.62M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 172.92M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 172.94M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 114.36M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 111.64M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $255.45M |
| Capex restated | Q3 2025 · Sep 30, 2024 | $256.92M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $284.67M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $350.91M |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $0 |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $48.62M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $548.24M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $750.54M |
| Cash And Equivalents restated | Q3 2025 · Sep 30, 2024 | $826.98M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $1.56B |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $1.53B |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $1.51B |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $1.48B |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $1.58B |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $1.09B |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $2.38B |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $2.34B |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $1.42B |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $1.32B |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $7.22B |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $7.42B |
| Current Assets | Q3 2025 · Sep 30, 2025 | $1.91B |
| Current Assets | Q3 2025 · Dec 31, 2024 | $2.13B |
| Total Assets | Q3 2025 · Sep 30, 2025 | $8.81B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $8.93B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $0.18 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $0.48 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.91 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$12.16 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $0.18 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $0.48 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.91 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$12.16 |
| Net Income | Q3 2025 · Sep 30, 2025 | $84.92M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$1.36B |
| Operating Income | Q3 2025 · Sep 30, 2025 | $52.05M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $168.21M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$149.72M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$1.76B |